65,437 trials
Irritable Bowel Syndrome (IBS)
Primary: Number of Participants With Average Adequate Relief Rate During the Last 4 Weeks of the Treatment Periods (Weeks 3-6. in Period 1, Weeks 12-15 in Period 2).
Opiate Dependence
Primary: Naltrexone Injections Received — 51.8; 86.8 Percentage of injections received — p==0.002
Hypomastia · Primary Breast Augmentation
Primary: Breast Q Augmentation Module — 494.5; 503.4; 420 units on a scale
Opiate Dependence
Primary: Percentage of Depot Naltrexone Doses Received — 42.2; 80.6 percentage of injections — p==0.008
Infectious Gastroenteritis
Primary: Analysis of Diarrheal Illness Etiologies Identified in Stool Culture Compared to the FilmArray™ Gastrointestinal (GI) Panel — 434; 19 Participants
Arrhythmia
Primary: The Number of Participants With Atrial Fibrillation — 26; 37 Participants
Multiple Sclerosis, Primary Progressive
Primary: Time to Onset of Clinical Disability Progression (CDP) Sustained for at Least 12 Weeks During the Double-Blind Treatment Period — NA; NA weeks
Chronic Obstructive Pulmonary Disease
Primary: Change From Baseline in Forced Expiratory Volume (FEV1) Area Under the Curve (AUC) 0-24h — 0.2321; 0.2436 Liters — p=0.139
Risperidone-induced Hyperprolactinemia
Primary: Trabecular Bone Mineral Density in the Ultradistal Radius — 192.9; 197.2; 191.0; 194.6 mg/cm^3
Obesity · Type 2 Diabetes
Primary: Pancreatic and Liver Fat — 1.87; 6.57; 3.61; 5.85 percent
Rheumatoid Arthritis
Primary: Change From Week 24 in Disease Activity Score Based on 28 Joints (DAS28) Score at Week 40 — 2.13; 2.11; 0.15; 0.48 units on a scale
Sickle Cell Disease
Primary: Percentage of Participants With Event-Free Survival (EFS) — 76; 69 percentage of participants
Cocaine Dependence
Primary: Cocaine Use/Treatment Effectiveness Score (TES) — 6.6; 8.3; 29 percentage of negative urines
Asthma · Bronchial Diseases · Respiratory Tract Diseases
Primary: Change in Rescue Inhaler Actuations/Person/Day — -0.37 puffs per participant per day
Age - Related Macular Degeneration (AMD)
Primary: Change in Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score From Baseline to Week 100 - Last Observation Carried Forward (LOCF) — 58.7; 4.5 letters…